Ionis Pharmaceuticals (IONS) Tax Provisions (2009 - 2026)

Ionis Pharmaceuticals' Tax Provisions history runs 18 years deep, the most recent figure standing at $1.3 million for Q2 2026.

• In Q2 2026, Tax Provisions rose 6420.0% year-over-year to $1.3 million; the TTM figure through Jun 2026 stood at -$78.3 million (up 18.95% YoY), while the FY2025 annual figure was -$79.7 million, up 17.49% from the prior year.
• Tax Provisions for Q2 2026 stood at $1.3 million, up from $218000.0 in the prior quarter.
• The five-year high for Tax Provisions was $11.4 million in Q1 2023, with the low at -$96.0 million in Q4 2023.
• The 5-year median for Tax Provisions is $164500.0 (2025), against an average of -$16.6 million.
• The sharpest annual moves came in 2022 and 2026: Tax Provisions sank 520.83% in 2022, then jumped 6420.0% in 2026.
• Ionis Pharmaceuticals' Tax Provisions stood at -$57.8 million in 2022, then plunged by 65.98% to -$96.0 million in 2023, then climbed by 2.96% to -$93.1 million in 2024, then gained by 14.06% to -$80.0 million in 2025, then soared by 101.58% to $1.3 million in 2026.
• Business Quant data shows IONS's Tax Provisions at $1.3 million in Q2 2026, $218000.0 in Q1 2026, and -$80.0 million in Q4 2025.